Both in Pharmaceuticals
Precigen vs Stoke Therapeutics
Over the past year PGEN returned +30.3% and STOK returned +8.3%; their daily moves had a correlation of 0.22.
PGEN +30.3% STOK +8.3%Growth of $1, one year, split-adjusted
| Metric | PGEN | STOK |
|---|---|---|
| Price | $5.06 | $27.45 |
| Market cap | $1.81B | $1.77B |
| Today | −3.71% | +1.70% |
| 1 month | −33.0% | +12.6% |
| 6 months | +14.9% | −17.5% |
| Year to date | +20.9% | −13.5% |
| 1 year | +21.5% | +5.2% |
| Revenue growth (YoY) | +6322.7% | +5.9% |
| Gross margin | 94.9% | 100.0% |
| Net margin | 36.5% | −654.3% |
| P/E (TTM) | — | — |
| Price / sales | 21.1× | 62.8× |
| Net cash | -$55.7M | $319.2M |
| Dividend yield | — | — |
| Volatility (60d) | 86.8% | 47.9% |
| Short % of float | 26.1% | 18.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).